Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial-Reference-Cited by-同舟云学术

Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

Published:2015-04-02 Issue:14 Volume:121 Page:2422-2430
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bruner Deborah W.¹,Hunt Daniel²,Michalski Jeff M.³,Bosch Walter R.⁴,Galvin James M.⁵,Amin Mahul⁶,Xiao Canhua¹,Bahary Jean-Paul⁷,Patel Malti⁸,Chafe Susan⁹,Rodrigues George¹⁰,Lau Harold¹¹,Duclos Marie¹²,Baikadi Madhava⁵,Deshmukh Snehal²,Sandler Howard M.⁶

Affiliation:

1. Nell Hodgson Woodruff School of Nursing; Emory University; Atlanta Georgia

2. Radiation Therapy Oncology Group-Statistical Center; Philadelphia Pennsylvania

3. Department or Radiation Oncology; Washington University; St. Louis Missouri

4. Image-Guided Therapy Quality Assurance Center; Washington University; St. Louis Missouri

5. Department of Radiation Oncology; Thomas Jefferson University Hospital

6. Department of Pathology and Laboratory Medicine; Cedars-Sinai Medical Center; Los Angeles California

7. Department of Radiation Oncology; University of Montreal Hospital Center-Notre Dame; Montreal Quebec Canada

8. Department of Radiation Oncology; Juravinski Cancer Center; Hamilton Ontario Canada

9. Department of Radiation Oncology; Cross Cancer Institute; Edmonton Alberta Canada

10. London Health Sciences Center; University of Western Ontario; London Ontario Canada

11. Department of Oncology; Tom Baker Cancer Center; Calgary Alberta Canada

12. Department of Oncology; McGill University; Montreal Quebec Canada

Funder

American Society for Radiation Oncology Radiation Oncology Institute

Radiation Therapy Oncology Group

Community Clinical Oncology Program

Advanced Technology Consortium

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29362/fullpdf

Reference30 articles.

1. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial;Beckendorf;Int J Radiat Oncol Biol Phys,2011

2. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial;Zietman;JAMA,2005

3. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial;Nutting;Lancet Oncol,2011

4. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program;Vergeer;Int J Radiat Oncol Biol Phys,2009

5. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with 3-dimensional conformal radiation therapy in clinically localized prostate cancer;Wang-Chesebro;Int J Radiat Oncol Biol Phys,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trial;Clinical and Translational Radiation Oncology;2024-07

2. Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma survivors;Oral Oncology;2024-07

3. Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-04

4. Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer;Cochrane Database of Systematic Reviews;2023-03-08

5. Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating 2 Ultrahypofractionated Regimens for Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2022-12